Filing Details
- Accession Number:
- 0001581760-25-000038
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-12 19:32:26
- Reporting Period:
- 2025-03-10
- Filing Date:
- 2025-03-12
- Accepted Time:
- 2025-03-12 19:32:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1581760 | Life360 Inc. | LIF | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1185999 | Philip John Coghlan | C/O Life360, Inc. 1900 South Norfolk Street, Suite 310 San Mateo CA 94403 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-03-10 | 3,125 | $42.53 | 35,669 | No | 4 | S | Indirect | Held by the John Coghlan Living Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | Held by the John Coghlan Living Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 64,834 | Indirect | Held by The John Philip Coghlan 2024 Grantor Retained Annuity Trust |
Common Stock | 5,226 | Direct |
Footnotes
- The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
- The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $42.25 to $43.00, inclusive, per share. The Reporting Personundertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separateprice within the range.
- Includes 1,742 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.